LexDanaLexDanabeta
Inventor

QIN MEI

Inventor
CN

Overview

5→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
G01NInvestigating or analysing materials by determining their chemical or physical properties22%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,485,298Anti-CD3epsilon antibodies202512,486,325Anti-CD3epsilon antibodies202512,410,250Anti-CD47 antibodies and uses thereof202511,440,962Anti-CD3epsilon antibodies202211,365,254Bispecific CD3/CD19 polypeptide complexes2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to WUXI BIOLOGICS IRELAND LTD (5)· patent assignee history
2022–2025Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WUXI BIOLOGICS IRELAND LTD52022–2025
Locations
LocationPatentsSpan
CN52022–2025